A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome - Related Studies

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

This study has been completed.

Study NCT00001839. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hematologic Diseases
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Neoplasms
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		Antithymocyte globulin
		Cyclosporine

5	Additional drug interventions recognized in this trial
		Antilymphocyte Serum
		Cyclosporins

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institutes of Health Clinical Center (CC)